uMedical
Medicines
Substances
Companies
Statistics
Menu
All medicines
Enviage
Withdrawn
Human
Details
EMA number
EMEA/H/C/000850
ATC code
C09XA02
Authorisation
22 August 2007
Withdrawn
27 September 2010
Revision
4
EMA page
Therapeutic indication
Treatment of essential hypertension
MeSH:
Hypertension
Group:
Agents acting on the renin-angiotensin system
Active substances
aliskiren
Marketing Authorisation Holder
Novartis Europharm Ltd
MAH
Timeline
Filter by authority:
EMA
Enviage withdrawn
27 Sept 2010
withdrawn
regulatory
Enviage authorised
22 Aug 2007
authorised
regulatory
Enviage | uMedical